129 related articles for article (PubMed ID: 26229429)
1. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():1365. PubMed ID: 26229429
[TBL] [Abstract][Full Text] [Related]
2. Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
Clin Ophthalmol; 2015; 9():453. PubMed ID: 25834381
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients.
Tsumura T; Yoshikawa K; Kimura T; Suzumura H; Kawashima M; Nanno M; Ishijima K; Takeda R
Clin Ophthalmol; 2014; 8():1681-7. PubMed ID: 25214761
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Jun; 34(6):1438-1448. PubMed ID: 28508306
[TBL] [Abstract][Full Text] [Related]
5. The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.
Whitson JT; Ochsner KI; Moster MR; Sullivan EK; Andrew RM; Silver LH; Wells DT; James JE; Bosworth CF; Dickerson JE; Landry TA; Bergamini MV;
Ophthalmology; 2006 Aug; 113(8):1333-9. PubMed ID: 16877072
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].
Int J Chron Obstruct Pulmon Dis; 2017; 12():231. PubMed ID: 28138232
[TBL] [Abstract][Full Text] [Related]
8. Brimonidine tartrate for the treatment of glaucoma.
Oh DJ; Chen JL; Vajaranant TS; Dikopf MS
Expert Opin Pharmacother; 2019 Jan; 20(1):115-122. PubMed ID: 30407890
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].
Neuropsychiatr Dis Treat; 2017; 13():2219. PubMed ID: 28860779
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.
LeBlanc RP
Ophthalmology; 1998 Oct; 105(10):1960-7. PubMed ID: 9787370
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum].
Ther Clin Risk Manag; 2016; 12():1083. PubMed ID: 27462161
[TBL] [Abstract][Full Text] [Related]
12. High Permeability and Intercellular Space Widening With Brimonidine Tartrate Eye Drops in Cultured Stratified Human Corneal Epithelial Sheets.
Hashimoto Y; Yokoo S; Usui T; Tsubota Y; Yamagami S
Cornea; 2018 Feb; 37(2):242-247. PubMed ID: 29135708
[TBL] [Abstract][Full Text] [Related]
13. Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits.
Dong JQ; Babusis DM; Welty DF; Acheampong AA; Tang-Liu D; Whitcup SM
J Ocul Pharmacol Ther; 2004 Aug; 20(4):285-92. PubMed ID: 15321023
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
Jin SW; Lee SM
J Ocul Pharmacol Ther; 2018 Apr; 34(3):274-279. PubMed ID: 29297751
[TBL] [Abstract][Full Text] [Related]
15. Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma.
Liu CJ; Ko YC; Cheng CY; Chou JC; Hsu WM; Liu JH
Br J Ophthalmol; 2002 Nov; 86(11):1236-9. PubMed ID: 12386077
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents [Corrigendum].
Clin Ophthalmol; 2018; 12():287. PubMed ID: 29440871
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of brimonidine 0.2% compared with timolol 0.5% in glaucoma: a randomized clinical trial on Taiwanese patients.
Chen MJ; Chou JC; Hsu WM; Liu JH
J Chin Med Assoc; 2003 May; 66(5):276-81. PubMed ID: 12908569
[TBL] [Abstract][Full Text] [Related]
18. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
Liu CJ; Ko YC; Cheng CY; Chiu AW; Chou JC; Hsu WM; Liu JH
Ophthalmology; 2002 Dec; 109(12):2241-7. PubMed ID: 12466165
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].
Int J Womens Health; 2015; 7():403. PubMed ID: 25960676
[TBL] [Abstract][Full Text] [Related]
20. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use.
Cantor LB
Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
